These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19644018)

  • 21. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells.
    Schlezinger JJ; Jensen BA; Mann KK; Ryu HY; Sherr DH
    J Immunol; 2002 Dec; 169(12):6831-41. PubMed ID: 12471115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
    Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
    ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of aromatase by nuclear receptors.
    Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells.
    Elstner E; Williamson EA; Zang C; Fritz J; Heber D; Fenner M; Possinger K; Koeffler HP
    Breast Cancer Res Treat; 2002 Jul; 74(2):155-65. PubMed ID: 12186376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor.
    Bruck R; Weiss S; Aeed H; Pines M; Halpern Z; Zvibel I
    Dig Dis Sci; 2009 Feb; 54(2):292-9. PubMed ID: 18594976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
    Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
    Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells.
    Ding X; Wang W; Wang M; Wu J; Yao F
    Biochem Biophys Res Commun; 2017 May; 487(2):189-193. PubMed ID: 28396148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.
    Papi A; De Carolis S; Bertoni S; Storci G; Sceberras V; Santini D; Ceccarelli C; Taffurelli M; Orlandi M; Bonafé M
    J Cell Physiol; 2014 Nov; 229(11):1595-606. PubMed ID: 24604522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Qi H; Belmonte M; Catalano S; Andò S
    Breast Cancer Res Treat; 2009 Feb; 113(3):423-34. PubMed ID: 18293083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
    Yamazaki K; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Kanemura N; Araki H; Tsurumi H; Kojima S; Weinstein IB; Moriwaki H
    Gut; 2007 Nov; 56(11):1557-63. PubMed ID: 17604322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
    Fan P; Abderrahman B; Chai TS; Yerrum S; Jordan VC
    Mol Cancer Ther; 2018 Dec; 17(12):2732-2745. PubMed ID: 30224430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
    Jiménez-Lara AM; Aranda A; Gronemeyer H
    Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy.
    Khandekar MJ; Banks AS; Laznik-Bogoslavski D; White JP; Choi JH; Kazak L; Lo JC; Cohen P; Wong KK; Kamenecka TM; Griffin PR; Spiegelman BM
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):561-566. PubMed ID: 29295932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells.
    Hacioglu C; Kar F; Kacar S; Sahinturk V; Kanbak G
    Med Oncol; 2021 Feb; 38(3):31. PubMed ID: 33599853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells.
    Tanaka T; Dancheck BL; Trifiletti LC; Birnkrant RE; Taylor BJ; Garfield SH; Thorgeirsson U; De Luca LM
    Mol Cell Biol; 2004 May; 24(9):3972-82. PubMed ID: 15082790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.